Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis
Corresponding Author
S. Nightingale
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Regional and University Department of Neurology, Queen Elizabeth Hospital, Birmingham B15 2TH, EnglandSearch for more papers by this authorE. Woo
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorJ. M. French
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorM. M. Gale
Middlesex Hospital Medical School, London and the International Institute of Human Nutrition, Abingdon, England
Search for more papers by this authorH. M. Sinclair
Middlesex Hospital Medical School, London and the International Institute of Human Nutrition, Abingdon, England
Search for more papers by this authorD. Bates
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorD. A. Shaw
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorCorresponding Author
S. Nightingale
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Regional and University Department of Neurology, Queen Elizabeth Hospital, Birmingham B15 2TH, EnglandSearch for more papers by this authorE. Woo
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorJ. M. French
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorM. M. Gale
Middlesex Hospital Medical School, London and the International Institute of Human Nutrition, Abingdon, England
Search for more papers by this authorH. M. Sinclair
Middlesex Hospital Medical School, London and the International Institute of Human Nutrition, Abingdon, England
Search for more papers by this authorD. Bates
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorD. A. Shaw
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne
Search for more papers by this authorAbstract
Abstract The fatty acid profiles of phosphatidyl ethanolamine (PE) and phosphatidyl choline (PC) of the red blood cells of 30 patients with mild inactive multiple sclerosis (MS) and 30 healthy controls were studied by gas chromatography. The groups were well matched for factors likely to influence tissue lipid levels, including diet. The MS patients showed a significant reduction in PE eicosapentaenoic acid (p = 0.009) especially in women, and an increase in both PE dihomo-gamma-linolenic acid (p = 0.004) and PC stearic acid (p = 0.04). No reduction in linoleic acid was observed in either the PC or PE fractions of the MS subjects. A similar study of the fatty acid profile in adipose tissue in 26 MS and 35 healthy controls found no detectable eicosapentaenoic acid in either group. However, whereas docosahexaenoic acid was not detectable in any MS patient, 40% of the controls had measurable levels varying from to 0.1 to 0.3% of total estimated fatty acid (p = 0.0003). No reduction in linoleic acid in MS subjects was observed. Supplementation with oral fish body oil demonstrated that n - 3 fatty acids were incorporated into red blood cells over 5 weeks and this occurred equally in MS and controls. The effects of oral supplementation on adipose tissue were studied after 1 and 2 years. Whereas many fatty acids such as linoleic acid were raised at 1 year, but did not rise subsequently, eicosapentaenoic acid and docosahexaenoic acid continued to rise through the 2-year period. Long chain n - 3 fatty acids such as eicosapentaenoic and docosahexaenoic acids may be important in the development of the central nervous system and may be relevant to the pathogenesis and treatment of MS.
REFERENCES
- 1 Tuna N, Logothetis J, Kammereck R. Fatty acids in spinal fluid and serum of patients with demyelinating disorders. Neurology 1963: 13: 381–385.
- 2 Cumings JN, Shortman RC, Skrbic T. Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease. J Clin Pathol 1965: 18: 641–644.
- 3 Montfoort A, Baker RWR, Thompson RHS, Zilkha KJ. Plasma phospholipids and their fatty acid composition in multiple sclerosis. J Neurol Neurosurg Psychiatry 1966: 29: 99–102.
- 4 Wolfgram F, Myers L, Ellison G, Knipprath W. Serum linoleic acid in multiple sclerosis. Neurology 1975: 25: 786–788.
- 5 Paty DW, Cousin HK, MacDonald LE. Linoleic acid in multiple sclerosis. Lancet 1975: 1: 1197–1198.
- 6 Heipertz R, Klauke W, Pilz H, Ritter G. Serum fatty acids in multiple sclerosis. J Neurol 1977: 214: 153–157.
- 7 Shukla VKS, Clausen, J. Linoleate and fatty acid patterns in serum lipids in multiple sclerosis. Acta Neurol Scand 1978: 57: 270–274.
- 8 Baker RWR, Thompson RHS, Zilkha KJ. Serum fatty acids in multiple sclerosis. J Neurol Neurosurg Psychiatry 1964: 27: 408–414.
- 9 Baker RWR, Sanders H, Thompson RHS, Zilkha KJ. Serum cholesterol linoleate levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 1965: 28: 212–217.
- 10 Baker RWR, Thompson RHS, Zilkha KJ. Changes in the amounts of linoleic acid in the serum of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1966: 29: 95–98.
- 11 Sanders H, Thompson RHS, Payling Wright H, Zilkha KJ. Further studies on platelet adhesiveness and serum cholesteryl linoleate levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 1968: 31: 321–325.
- 12 Tichy J, Vymazal J. Changes in some serum fatty acids and lipids in relation to the clinical course of multiple sclerosis. Acta Neurol Scand 1973: 49: 345–354.
- 13 Tichy J, Vymazal J, Michalec C. Serum lipoproteins, cholesterol esters, and phospholipids in multiple sclerosis. Acta Neurol Scand 1969: 45: 32–40.
- 14 Belin J, Pettet N, Smith AD, Thompson RHS, Zilkha KJ. Linoleate metabolism in multiple sclerosis. J Neurol Neurosurg Psychiatry 1971: 34: 25–29.
- 15 Kalofoutis A, Jullien G. A study of serum fatty acids in neurological diseases. Biochimie 1974: 56: 623–624.
- 16 Love WC, Cashell A, Reynolds M, Callaghan N. Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases. Br Med J 1974: 3: 18–21.
- 17 Crawford MA, Hassam AG. Diagnostic test for multiple sclerosis. Br Med J 1975: 1: 150–151.
- 18 Tsang WM, Belin J, Munro JA, Smith AD, Thompson RHS, Zilkha KJ. Relationship between plasma and lymphocyte linoleate in multiple sclerosis. J Neurol Neurosurg Psychiatry 1976: 39: 767–771.
- 19 Neu IS. Essential fatty acids in serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol Scand 1983: 67: 151–163.
- 20 Cherayil GD. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis. J Neurol Sci 1984: 63: 1–10.
- 21 Gul S, Smith AD, Thompson RHS, Payling Wright H, Zilkha KJ. Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J Neurol Neurosurg Psychiatry 1970: 33: 506–510.
- 22 Homa ST, Belin J, Smith AD, Munro JA, Zilkha KJ. Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1980: 43: 106–110.
- 23 Andreoli VM, Cazzullo CL. Plasma and platelet phospholipids in multiple sclerosis patients. Life Sci 1969: 8: 327–334.
- 24 Andreoli VM, Maffei F, Tonon GC. Platelet lipid modifications induced by fatty acids. Experimental studies and correlations with human neuropathology. Haemostasis 1973: 2: 118–140.
- 25 Swank RL. Multiple sclerosis: a correlation of its incidence with dietary fat. Am J Med Sci 1950: 220: 421–430.
- 26 Sinclair HM. Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet 1956: 1: 381–383.
- 27 Allison RS. Some neurological aspects of medical geography. Proc R Soc Med 1963: 56: 71–76.
- 28 Mertin J, Meade CJ. Relevance of fatty acids in multiple sclerosis. Br Med Bull 1977: 33: 67–71.
- 29 Millar JHD, Zilkha KJ, Langman MJS. et al. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J 1973: 1: 765–768.
- 30 Bates D, Fawcett PRW, Shaw DA, Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J 1978: 2: 1390–1391.
- 31 Paty DW, Cousin HK, Read S, Adlakha K. Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit. Acta Neurol Scand 1978: 58: 53–58.
- 32 Dworkin RH, Bates D, Millar JHD, Paty DW. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology 1984: 34: 1441–1445.
- 33 Sanders TAB, Vickers M, Haines AP. Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men. Clin Sci 1981: 61: 317–324.
- 34 McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. Br Med Bull 1977: 33: 4–8.
- 35 Bates D, Cartlidge NEF, French JM. et al. A double-blind controlled trial of n - 3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989: 52: 18–22.
- 36 Kurtzke JF. On the evaluation of disability in multiple sclerosis. Neurology 1961: 11: 686–694.
- 37 Paul AA, Southgate DAT. McCance & Widdowson: The composition of foods. London : HMSO, 1978.
- 38
Rosnowska M,
Cendrowski W.
The effect of dietary supplementation of enriched marine oil on serum levels of w-3 and w-6 polyunsaturated fatty acids in multiple sclerosis. In: RE Gonsette,
P Delmotte, eds.
Immunological and clinical aspects of multiple sclerosis.
Lancaster
: MTP Press 1984, pp. 91–98.
10.1007/978-94-011-6352-1_22 Google Scholar
- 39 O'Brien JS, Sampson EL. Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res 1965: 6: 545–551.
- 40 Kishimoto Y, Radin NS, Tourtelotte WW, Parker JA, Itabashi HH. Gangliosides and glycerophosphates in multiple sclerosis white matter. Arch Neurol 1967: 16: 44–54.
- 41
Crawford MA,
Sinclair AJ.
Nutritional influences in the evolution of mammalian brain. In: Lipids, malnutrition and the developing brain. Elsevier:
London
, 1972: 267–287.
10.1002/9780470719862.ch16 Google Scholar
- 42 Crawford MA, Casperd NM, Sinclair AJ. The long-chain metabolites of linoleic and linolenic acids in liver and brain in herbivores and carnivores. Comp Biochem Physiol 1976: 54B: 395–401.
- 43 Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and the prevention of thrombosis and atherosclerosis. Lancet 1978: 2: 117–119.
- 44 Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979: 2: 433–435.
- 45 Terano T, Hirai A, Hamazaki T. et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability on healthy human subjects. Atherosclerosis 1983: 46: 321–331.
- 46 Lee TH, Hoover RL, Williams JD. et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985: 312: 1217–1224.
- 47 Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985: 312: 1210–1216.
- 48 Knapp HR, Reilly IAG, Alessandrini P, Fitzgerald GA. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986: 314: 937–942.
- 49 Payan DG, Wong MY, Chernov-Rogan T. et al. Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol 1986: 6: 402–410.
- 50 Endres S, Ghorbani R, Kelly VE. et al. The effects of dietary supplementation with n - 3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989: 320: 265–271.
- 51 Norris PG, Jones CJH, Weston MJ. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hyupertension. Br Med J 1986: 293: 104–105.
- 52 Lee TH, Arm JP. Benefits from oily fish. Br Med J 1988: 297: 1421–1422.
- 53 Anon. Fish Oil. Lancet 1988: 1: 1081–1083.
- 54 Dyerberg J. Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev 1986: 44: 125–134.
- 55 Holman RT, Johnson RB, Hatch TF. A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr 1982: 35: 617–623.
- 56 Neuringer M, Connor WE. n - 3 fatty acids in the brain and retina: evidence for their essentiality. Nutr Rev 1986: 44: 285–294.
- 57 Mertin J. Omega-6 and omega-3 polyunsaturates and the immune system. Br J Clin Pract [Symp Suppl] 1984: 38: 111–114.
- 58 Davson H. The physiology of cerebrospinal fluid. London : Churchill, 1967.
- 59
Dean G.
Epidemiology of multiple sclerosis.
Neuroepidemiology
1984: 3: 58–73.
10.1159/000110843 Google Scholar
- 60 Sinclair HM. The importance of fish oil in prevention of chronic degenerative disorders. In: H Noelle, ed. Food from the sea. Berlin : Springer-Verlag 1981: 201–210.
- 61 Crawford MA, Hassam AG, Williams G, Whitehouse WL. Essential fatty acids and fetal brain growth. Lancet 1976: 1: 452–453.
- 62 Neuringer M, Connor WE, Petten CV, Barstad L. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J Clin Invest 1984: 73: 272–276.
- 63 Bernsohn J, Stephanides LM. Aetiology of multiple sclerosis. Nature 1967: 215: 821–823.
- 64 Connor WE, Neuringer M, Lin D. The incorporation of docosahexaenoic acid into the brain of monkeys deficient in w-3 essential fatty acids. Clin Res 1985: 33: 598A.
- 65 Hamazaki T, Tateno S, Shishido H. Eicosapentaenoic acid and IgA nephropathy. Lancet 1984: 1: 1017–1018.
- 66 Kremer JM, Bigauoette J, Michalek AV, et al. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985: 1: 184–187.
- 67 Kremer JM, Jubiz W, Michalek AV, et al. Fish-oil fatty supplementation in active rheumatoid arthritis; a double-blind, controlled, crossover study. Ann Intern Med 1987: 106: 497–503.
- 68 Bittiner SB, Tucker WFG, Cartwright I, Bleehen SS. A double-blind, randomized, placebo-controlled trial of fish oil in psoriasis. Lancet 1988: 1: 378–380.